RESTRICTED STOCK PURCHASE AGREEMENTRestricted Stock Purchase Agreement • March 22nd, 2005 • Avicena Group, Inc. • Delaware
THIS RESTRICTED STOCK PURCHASE AGREEMENT (this “Agreement”) is made as of February 9, 2005, between Avicena Group, Inc., a Delaware corporation (the “Company”), and Belinda Tsao Nivaggioli (“Employee”).
RESTRICTED STOCK PURCHASE AGREEMENTRestricted Stock Purchase Agreement • March 22nd, 2005 • Avicena Group, Inc. • Delaware
THIS RESTRICTED STOCK PURCHASE AGREEMENT (this “Agreement”) is made as of February 9, 2005, between Avicena Group, Inc., a Delaware corporation (the “Company”), and Nasser Menhall (“Recipient”).
AGREEMENT AND PLAN OF MERGER dated as of March 9, 2005 between AVICENA GROUP, INC. and AVN ACQUISITION CORP.Agreement and Plan of Merger • March 22nd, 2005 • Avicena Group, Inc. • Delaware
THIS AGREEMENT AND PLAN OF MERGER dated as of March 9, 2005 (the “Agreement”), between AVICENA GROUP, INC., a Delaware corporation (“Avicena”), and AVN ACQUISITION CORP., a Delaware corporation (“AVN”);
SERIES C FINANCIAL ADVISORY AGREEMENTSeries C Financial Advisory Agreement • March 22nd, 2005 • Avicena Group, Inc. • Delaware
THIS FINANCIAL ADVISORY AGREEMENT is made as of March 11, 2002 by and between Avicena Group, Inc., a Delaware corporation with its principal place of business at One Cambridge Center, 5th Floor, Cambridge, MA 02142 (the “Company”), and H.K. Properties Limited, an Isle of Man company with an office at c/o WorldCare, 11 rue de la Boetie, Paris, France 75008 (the “Advisor”).
ContractTerms of an Agreement • March 22nd, 2005 • Avicena Group, Inc. • Delaware
Terms of an Agreement (the “AGREEMENT”) for purchase and sale of Drug GMP Creatine Monohydrate (“CREATINE”) between the following: The Avicena Group, Inc., 228 Hamilton Avenue, 3rd Floor, Palo Alto CA 94301 T, USA (“AVICENA”) and Degussa AG, Dr.-Albert-Frank-StraBe 32, 83308 Trostberg, Germany (“DEGUSSA”), (sometimes hereinafter collectively referred to as the “PARTIES”), on their own respective behalves.
SUPPLY, LICENSE AND DEVELOPMENT AGREEMENTSupply, License and Development Agreement • March 22nd, 2005 • Avicena Group, Inc. • Massachusetts
THIS SUPPLY, LICENSE AND DEVELOPMENT AGREEMENT is made and entered into as of August 17, 2000, by and between THE AVICENA GROUP, INC., a Delaware corporation having offices at One Cambridge Center, Fifth Floor, Cambridge, Massachusetts 02142 (“Avicena”), and ESTÉE LAUDER, INC., a Delaware corporation having offices at Research Park, 125 Pinelawn Road, Melville, New York 11747 (together with its affiliates, “Estée Lauder”).
NOTEAvicena Group, Inc. • March 22nd, 2005
FOR VALUE RECEIVED, the undersigned, AVICENA GROUP, INC., having an address of 228 Hamilton Avenue, Third Floor, Palo Alto, CA 94301 (the “Borrower”), hereby promises to pay to the order of AVN ACQUISITION CORP., having an address of 497 Delaware Avenue, Buffalo, New York 14202 (the “Lender”), the principal sum of Two Hundred Fifty Thousand and no/100 dollars ($250,000.00) (All monetary amounts herein are expressed in U.S. Dollars). Principal on this Note shall be payable on May 31, 2006, or such earlier date as the Borrower shall complete its proposed merger with Lender. Interest on the outstanding principal amount shall accrue at the rate of eight percent (8%) per annum, payable on December 31 for so long as this Note shall remain outstanding and at Maturity.
LOAN AGREEMENT BETWEEN AVICENA GROUP, INC. AND AVN ACQUISITION CORP.Loan Agreement • March 22nd, 2005 • Avicena Group, Inc. • Delaware
LOAN AGREEMENT dated as of February 7, 2005 (the “Agreement”), between AVN Acquisition Corp., a corporation organized and existing under the laws of the State of Delaware (the “Lender”), and Avicena Group, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Company”).
